BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38182561)

  • 1. Effects of methionine deficiency on B7H3-DAP12-CAR-T cells in the treatment of lung squamous cell carcinoma.
    Yu T; Nie FQ; Zhang Q; Yu SK; Zhang ML; Wang Q; Wang EX; Lu KH; Sun M
    Cell Death Dis; 2024 Jan; 15(1):12. PubMed ID: 38182561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on construction of c-Met specific CAR-T cells and its killing effect on non-small cell lung carcinoma].
    Min JT; Zhang L; Long CR; Fan HL; Li ZZ
    Zhonghua Zhong Liu Za Zhi; 2023 Apr; 45(4):322-329. PubMed ID: 37078213
    [No Abstract]   [Full Text] [Related]  

  • 3. Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma.
    Sakunrangsit N; Khuisangeam N; Inthanachai T; Yodsurang V; Taechawattananant P; Suppipat K; Tawinwung S
    Cancer Immunol Immunother; 2024 Apr; 73(6):98. PubMed ID: 38619641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPC3-targeted CAR-T cells secreting B7H3-targeted BiTE exhibit potent cytotoxicity activity against hepatocellular carcinoma cell in the in vitro assay.
    Cao G; Zhang G; Liu M; Liu J; Wang Q; Zhu L; Wan X
    Biochem Biophys Rep; 2022 Sep; 31():101324. PubMed ID: 36032401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor responses in gastric cancer by targeting B7H3 via chimeric antigen receptor T cells.
    Sun F; Yu X; Ju R; Wang Z; Wang Y
    Cancer Cell Int; 2022 Jan; 22(1):50. PubMed ID: 35101032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR/Ferroptosis in lung squamous cell carcinoma.
    Shan G; Minchao K; Jizhao W; Rui Z; Guangjian Z; Jin Z; Meihe L
    J Pharm Biomed Anal; 2023 May; 229():115346. PubMed ID: 37001272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated Th1 cells in lung squamous cell carcinoma.
    Wang J; Zhou J; Zhou Q; Qi Y; Zhang P; Yan C; Ren X
    J Leukoc Biol; 2022 Dec; 112(6):1567-1576. PubMed ID: 35686499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of CAR-T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins.
    Qiao Y; Chen J; Wang X; Yan S; Tan J; Xia B; Chen Y; Lin K; Zou F; Liu B; He X; Zhang Y; Zhang X; Zhang H; Wu X; Lu L
    Cancer Commun (Lond); 2023 Jul; 43(7):788-807. PubMed ID: 37282786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma.
    Wang Y; Ji N; Zhang Y; Chu J; Pan C; Zhang P; Ma W; Zhang X; Xi JJ; Chen M; Zhang Y; Zhang L; Sun T
    J Transl Med; 2023 Sep; 21(1):672. PubMed ID: 37770968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors.
    Yuan X; Sun Z; Yuan Q; Hou W; Liang Q; Wang Y; Mo W; Wang H; Yu M
    Invest New Drugs; 2021 Feb; 39(1):34-51. PubMed ID: 32772342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Met specific CAR-T cells as a targeted therapy for non-small cell lung cancer cell A549.
    Min J; Long C; Zhang L; Duan J; Fan H; Chu F; Li Z
    Bioengineered; 2022 Apr; 13(4):9216-9232. PubMed ID: 35378051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma.
    Guo Q; Wu CY; Jiang N; Tong S; Wan JH; Xiao XY; Mei PY; Liu HS; Wang SH
    Front Immunol; 2022; 13():986447. PubMed ID: 36544782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance.
    Yang M; Lin C; Wang Y; Chen K; Zhang H; Li W
    Genome Med; 2022 Jul; 14(1):72. PubMed ID: 35799269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting sphingosine 1-phosphate receptor 3 inhibits T-cell exhaustion and regulates recruitment of proinflammatory macrophages to improve antitumor efficacy of CAR-T cells against solid tumor.
    Gao G; Liao W; Shu P; Ma Q; He X; Zhang B; Qin D; Wang Y
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37591632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T Cells Expressing NKG2D CAR with a DAP12 Signaling Domain Stimulate Lower Cytokine Production While Effective in Tumor Eradication.
    Ng YY; Tay JCK; Li Z; Wang J; Zhu J; Wang S
    Mol Ther; 2021 Jan; 29(1):75-85. PubMed ID: 32956627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity.
    Hickman TL; Choi E; Whiteman KR; Muralidharan S; Pai T; Johnson T; Parikh A; Friedman T; Gilbert M; Shen B; Barron L; McGinness KE; Ettenberg SA; Motz GT; Weiss GJ; Jensen-Smith A
    PLoS One; 2022; 17(5):e0266980. PubMed ID: 35507536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of adenosine 2A receptor improves the anti-tumor function of anti-mesothelin CAR T cells both in vitro and in vivo.
    Liu G; Zhang Q; Liu G; Li D; Zhang L; Gu Z; Tian H; Zhang Y; Tian X
    Exp Cell Res; 2021 Dec; 409(1):112886. PubMed ID: 34673000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer.
    Cao B; Liu M; Wang L; Zhu K; Cai M; Chen X; Feng Y; Yang S; Fu S; Zhi C; Ye X; Zhang J; Zhang Z; Yang X; Zhao M; Wu Q; Xu L; Yang L; Lian H; Zhao Q; Zhang Z
    Nat Commun; 2022 Oct; 13(1):6203. PubMed ID: 36261437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies.
    Jie Y; Liu G; Feng L; Li Y; E M; Wu L; Li Y; Rong G; Li Y; Wei H; Gu A
    Front Immunol; 2021; 12():665970. PubMed ID: 34475869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of tumour-infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma.
    Lu J; Duan Y; Liu P; He X; Yang Y; Zhang R; Weng L
    J Pathol; 2023 Jan; 259(1):21-34. PubMed ID: 36178315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.